Recent Finacing
Recent Raise
PhosImmune is a clinical-stage biotechnology company in Charlottesville developing cancer vaccines from a UVA-derived library of aberrantly phosphorylated tumor antigens; lead candidate PxM-01 is in Phase I melanoma trials.
Focus Areas
Recent Investors
Funding round
Investor